Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lavina Lickley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer|July 19, 2002
Prophylactic bilateral mastectomy: patterns of practiceKelly A Metcalfe, Vivek Goel, Lavina Lickley, et al.
Clinical Medicine. Oncology|September 6, 2011
Biological Markers Predictive of Invasive Recurrence in DCISSharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, et al.
Breast Cancer Research and Treatment|November 30, 2004
Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stageHarriette J Kahn, Anthony Presta, Lu-Ying Yang, et al.
Cancer Informatics|September 10, 2008
Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breastDavid E Axelrod, Naomi A Miller, H Lavina Lickley, et al.
Breast Cancer Research and Treatment|January 25, 2005
Prognostic factors affecting the natural history of node-negative breast cancerMaureen E Trudeau, Kathleen I Pritchard, Judy-Anne W Chapman, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer|July 19, 2002
Prophylactic bilateral mastectomy: patterns of practiceKelly A Metcalfe, Vivek Goel, Lavina Lickley, et al.
Clinical Medicine. Oncology|September 6, 2011
Biological Markers Predictive of Invasive Recurrence in DCISSharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, et al.
Breast Cancer Research and Treatment|November 30, 2004
Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stageHarriette J Kahn, Anthony Presta, Lu-Ying Yang, et al.
Cancer Informatics|September 10, 2008
Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breastDavid E Axelrod, Naomi A Miller, H Lavina Lickley, et al.
Breast Cancer Research and Treatment|January 25, 2005
Prognostic factors affecting the natural history of node-negative breast cancerMaureen E Trudeau, Kathleen I Pritchard, Judy-Anne W Chapman, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Pageof 1